Highlights
- •MMD is a cerebrovascular disease manifesting with ischemic or hemorrhagic symptoms.
- •This disease is mainly studied in Asian populations due to its high prevalence.
- •In the US, presentations of MMD are associated with patient age, gender, and race.
Abstract
Background
Methods
Results
Conclusions
Keywords
Abbreviations:
ICD-9-CM (International Classification of Disease 9th edition Clinical Modification), ICD-10-CM (International Classification of Diseases 10th edition Clinical Modification), ICH (Intracranial hemorrhage), MMD (Moyamoya disease), NIS (Nationwide Inpatient Sample), TIA (Transient ischemic attack)Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Clinical NeuroscienceReferences
- Hypoplasia of the bilateral internal carotid arteries.Brain Nerve. 1957; 9: 27-32
- Moyamoya disease: a review of the disease and anesthetic management.J Neurosurg Anesthesiol. 2011; 23: 100-109https://doi.org/10.1097/ANA.0b013e3181f84fac
- Moyamoya disease in the United States.Clin Neurol Neurosurg. 1997; 99: S26-S30https://doi.org/10.1016/S0303-8467(97)00060-7
- Moyamoya disease.Neuropathology. 2000; 20: S61-S64https://doi.org/10.1046/j.1440-1789.2000.00300
- Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26.Am J Hum Genet. 1999; 64: 533-537https://doi.org/10.1086/302243
- Moyamoya vasculopathy with anti-SCL-70 antibodies: a case report and review of the literature.J Clin Neurosci. 2018; 56: 177-179https://doi.org/10.1016/j.jocn.2018.06.055
Chen J, Jiang X, Shi Y, Yuan F, Hu Z. Systemic sclerosis associated with moyamoya syndrome: a case report and literature review. Immunobiology. 2019;[epub ahead of print]. 10.1016/j.imbio.2019.11.017.
- Moyamoya disease associated with fibromuscular dysplasia of intrapulmonary bronchial arteries—a case report.Cardiovasc Pathol. 2020; 45: 107182https://doi.org/10.1016/j.carpath.2019.107182
- Moyamoya disease: a summary.Neurosurg Focus. 2009; 26: E11https://doi.org/10.3171/2009.1.FOCUS08310
- Worldwide distribution of moyamoya disease.Neurol Med Chir (Tokyo). 1992; 32: 883-886https://doi.org/10.2176/nmc.32.883
- Moyamoya in a non-Asian patient: a case report and review of the literature.W V Med J. 2012; 108: 18-19
- Moyamoya disease and moyamoya syndrome.N Eng J Med. 2009; 360: 1226-1237https://doi.org/10.1056/NEJMra0804622
- Trends in hospitalizations and epidemiological characteristics of adults Moyamoya disorder in the United States.J Neurol Sci. 2020; 419: 117165https://doi.org/10.1016/j.jns.2020.117165
- Moyamoya disease.Front Neurol Neurosci. 2016; 40: 204-220https://doi.org/10.1159/000448314
- Clinical presentation of Moyamoya angiopathy in Europeans: experiences from Germany with 200 patients.J Neurol. 2019; 266: 1421-1428https://doi.org/10.1007/s00415-019-09277-1
Feghali J, Xu R, Yang W, et al. Racial phenotypes in moyamoya disease: a comparative analysis of clinical presentation and natural history in a single multiethnic cohort of 250 hemispheres [published online ahead of print, 2019 Oct 4]. J Neurosurg 2019;1-7. doi:10.3171/2019.7.JNS191507.
Thompson NR, Fan Y, Dalton JE, et al. A new elixhauser-based comorbidity summary measure to predict in-hospital mortality: medical care. 2015;53:374-379. doi:10.1097/MLR.0000000000000326.
Khan N, Achrol AS, Guzman R, et al. Sex differences in clinical presentation and treatment outcomes in Moyamoya disease. Neurosurgery 2012;71(3):587-593. doi:10.1227/NEU.0b013e3182600b3c.
- A genome-wide association study identifies RNF213 as the first Moyamoya disease gene.J Hum Genet. 2011; 56: 34-40https://doi.org/10.1038/jhg.2010.132
- A novel susceptibility locus for moyamoya disease on chromosome 8q23.J Hum Genet. 2004; 49: 278-281https://doi.org/10.1007/s10038-004-0143-6
- Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development.PLoS ONE. 2011; 6: e22542https://doi.org/10.1371/journal.pone.0022542
- Molecular analysis of RNF213 gene for moyamoya disease in the Chinese Han population.PLoS ONE. 2012; 7: 2012https://doi.org/10.1371/journal.pone.0048179
Cecchi AC, Guo D, Ren Z, Flynn K, Santos-Cortez RL, Leal SM, et al. RNF213 rare variants in an ethnically diverse population with Moyamoya disease. Stroke.
- Vascular tortuosity of the internal carotid artery is related to the RNF213 c.14429G > A variant in moyamoya disease.Sci Rep. 2019; 9: 8614https://doi.org/10.1038/s41598-019-45141-y
- Association between p. R4810K variant and long-term clinical outcome in patients with moyamoya disease.Front Neurol. 2019; 10: 662https://doi.org/10.3389/fneur.2019.00662
- Clinical features of moyamoya disease in the United States.Stroke. 1998; 29: 1347-1351https://doi.org/10.1161/01.STR.29.7.1347
- Neurology-psychiatry interface: uncommon presentation of moyamoya disease.J Neurosci Rural Pract. 2019; 10: 526-528https://doi.org/10.1055/s-0039-1697246
- A child with moyamoya disease: mimicking the presentation of panic attack.Psychiatry Res. 2020; 285: 112720https://doi.org/10.1016/j.psychres.2019.112720
Indorewalla KK, McArdle M, Tomlinson E, Piryatinsky I. Neuropsychological profile associated with moyamoya disease: a case report. NeuroRehabilitation 2019;[epub ahead of print]. doi:10.3233/NRE-192903.
- Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease: results of multicenter survey in Japan.Stroke. 2007; 38: 1430-1435https://doi.org/10.1161/STROKEAHA.106.478297
Alluri RK, Leland H, Heckmann N. Surgical research using national databases. Ann Transl Med 2016;4:393. doi:10.21037/atm.2016.10.49.
Bekkers S, Bot AGJ, Makarawung D, et al. The national hospital discharge survey and nationwide inpatient sample: the databases used affect results in THA research. Clin Orthop Relat Res 2014;472:3441–3449. doi:10.1007/s11999-014-3836-y.
Karhade AV, Larsen AMG, Cote DJ, et al. National databases for neurosurgical outcomes research: options, strengths, and limitations. Neurosurg 2018;83:333-344. doi:10.1093/neuros/nyx408.
